I'm LongbridgeAI, I can summarize articles.Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen today and set a price target of $457.00. According to TipRanks, Amsellem is a 5-star analyst with an average return of 15.4% and a 60.12% success rate. Amsellem covers the Healthcare sector, focusing on stocks such as Amgen, AbbVie, and Teva Pharmaceutical. In addition to Piper Sandler, Amgen also received a Buy from Scotiabank’s Louise Chen in a report issued today. However, on the same day, Truist Financial maintained a Hold rating on Amgen (NASDAQ: AMGN).
Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen today and set a price target of $457.00.
According to TipRanks, Amsellem is a 5-star analyst with an average return of 15.4% and a 60.12% success rate. Amsellem covers the Healthcare sector, focusing on stocks such as Amgen, AbbVie, and Teva Pharmaceutical.
In addition to Piper Sandler, Amgen also received a Buy from Scotiabank’s Louise Chen in a report issued today. However, on the same day, Truist Financial maintained a Hold rating on Amgen (NASDAQ: AMGN).